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Abstract
The early incorporation of exposure assessment can be invaluable to help design, prioritize, and 
interpret toxicological studies or outcomes. The sum total of the exposure assessment findings 
combined with preliminary toxicology results allows for exposure-informed toxicological study 
design and the findings can then be integrated, together with available epidemiologic data, to 
provide health effect relevance. With regard to engineered nanomaterial inhalation toxicology in 
particular, a single type of material (e.g. carbon nanotube, graphene) can have a vast array of 
physicochemical characteristics resulting in the potential for varying toxicities. To compound the 
matter, the methodologies necessary to establish a material adequate for in vivo exposure testing 
raises questions on the applicability of the outcomes. From insights gained from evaluating carbon 
nanotubes, we recommend the following integrated approach involving exposure-informed hazard 
assessment and hazard-informed exposure assessment especially for materials as diverse as 
engineered nanomaterials: 1) market-informed identification of potential hazards and potentially 
exposed populations, 2) initial toxicity screening to drive prioritized assessments of exposure, 3) 
development of exposure assessment-informed chronic and sub-chronic in vivo studies, and 4) 
conduct of exposure- and hazard-informed epidemiological studies.
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1. Introduction
As formulated in the National Academy of Sciences/National Research Council for risk 
assessment/risk management (NRC, 1983, 2009), risk assessment itself has four integral 
parts including hazard identification, dose-response assessment, and exposure assessment 
that lead to risk characterization. In schematic representations of the paradigm, the dose-
response and exposure assessments contribute to the risk characterization but are oftentimes 
treated independently. For well-defined xenobiotics this would seem adequate, but with 
regard to the complexity of the physicochemical characteristics of engineered nanomaterials, 
an integration between exposure and toxicological assessments is a necessity. An early 
review of nanotoxicology as an emerging discipline indicated that exposure assessment 
could be informative for dose-response assessments (Oberdorster, Oberdorster, & 
Oberdorster, 2005).
2. Risk and exposure assessments
2.1. Knowledge-of-exposure and knowledge-of-hazard influence the relevance and 
reliability of risk assessments
Risk, in reference to particle toxicology, is an evaluation of the relative hazard of a material 
taking into account the exposure, or more specifically, the delivered dose. If little to no 
knowledge exists for the hazard and exposure then the risk will be poorly understood. 
Having only thorough knowledge of the hazard without any exposure data will also limit the 
interpretation of the findings. Conversely, knowing all facets of the exposure with little 
hazard information provides no indication of the risk. Once both detailed exposure 
assessments are performed in association with properly designed and executed toxicological 
evaluations using relevant exposure metrics then assessments of risk are likely to be valid 
(Fig. 1). An additional need is for an understanding of the factors involved in transferring 
risk observed from animal toxicology studies to human exposures and health effects 
(NIOSH, 2013). Ideally, epidemiologic studies would be available as a source of hazard 
identification or dose-response information, or to corroborate risk projections from 
toxicology and exposure assessment studies and to serve, potentially, as an additional data 
source for risk assessment (Vermeulen et al., 2014).
2.2. A framework to integrate exposure and toxicity assessments for engineered 
nanomaterials
In the adaptive risk assessment paradigm, risk characterization arises from hazard 
identification and subsequent dose-response assessments as well as exposure assessments. 
With regard to engineered nanomaterial inhalation toxicology, a single type of material (e.g. 
carbon nanotube, graphene) can have a vast array of physicochemical characteristics 
resulting in the potential for varying toxicities. To compound the matter, the methodologies 
necessary to establish a material adequate for in vivo exposure testing raises questions on the 
applicability of the outcomes. The early incorporation of exposure assessment can be 
invaluable to help design, prioritize, and interpret toxicological studies or outcomes (Fig. 2). 
Initially there needs to be an identification and prioritization of hazards and exposed 
populations (Schubauer-Berigan, Dahm, & Yencken, 2011). The decision should be market-
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informed with a reasonable anticipation of potential toxicity. Toxicity screening then drives 
prioritized assessments of exposure. The exposure assessments provide information about 
routes of exposure, levels of exposure, and material characteristics. When feasible, there 
should be congruence among exposure metrics being used, or reasonable extrapolations 
from the workplace to toxicology studies may be unreliable. While surface area of particles 
has significant relevance when considering toxicological outcomes, particularly for 
engineered nanomaterials, there is no reliable way to measure this metric in the workplace 
for materials such as carbon nanotubes (Dahm, Evans, Schubauer-Berigan, Birch, & 
Deddens, 2013). In addition, a recent study of various graphite nanoplates showed an inverse 
relationship between surface area and toxicity.
To make informed interpretations between toxicological and exposure assessments the 
evaluation of the toxicant should be categorically representative. This is important for 
engineered nanomaterials that may have varying levels of toxicity within a single class of 
material. For example, a particular multi-walled carbon nanotube (MWCNT), Mitsui-7 or 
MWCNT-7, has a count mean width of 49 nm for individual fibers (Porter et al., 2010) and 
during inhalation exposures has a count median width of 100.3 nm and a count median 
length of 3.04 μm during inhalation exposure (Chen et al., 2012). MWCNT-7 causes 
fibrosis, promotes lung tumorigenesis, and translocates to the pleural cavity and 
extrathoracic organs following an inhalation exposure designed to administer a nearly 100% 
respirable fraction (Chen et al., 2012; Grosse et al., 2014; Mercer, Scabilloni, Hubbs, Battelli 
et al., 2013; Mercer, Scabilloni, Hubbs, Wang, et al., 2013; Sargent et al., 2014). Conversely, 
exposure assessment studies have indicated that MWCNT used in U.S. facilities are more 
often smaller in diameter, resulting in significantly more nanotube agglomeration, which 
should decrease the likelihood of extrathoracic translocation (Dahm, Evans, Schubauer-
Berigan, Birch, & Fernback, 2012; Dahm et al., 2015). These factors may create different 
outcomes than described for MWCNT-7 and perhaps alter the risk characterization.
There is no clear answer on the exposure assessment side for how many evaluations would 
be representative of a single industry but caution should be used when designing 
toxicological studies or interpreting findings to human health relevance based on one or two 
observations. For example, personal breathing zone measurements for a facility 
manufacturing carbon nanofibers (CNF) had exposures of 45 and 80 μg/m3 of elemental 
carbon in the respirable size range (Birch, Ku, Evans, & Ruda-Eberenz, 2011). However, in 
a recently published study by Dahm et al. (2015) the authors found inhalable CNF personal 
breathing zone exposures of 4.2 and 7.5 μg/m3 of elemental carbon at a downstream 
manufacturing facility. Exposures at the respirable size fraction were not collected in this 
instance, but it can be assumed that respirable portion would only comprise a small 
percentage of the exposure based on transmission electron microscopy (TEM) and dustiness 
data (Dahm et al., 2015; Erdely et al., 2013; Evans, Turkevich, Roettgers, Deye, & Baron, 
2013). Since these are the only two CNF facilities where mass based measurements of 
elemental carbon has been collected, it is still relatively unclear whether these measurements 
are representative of the industry or just these particular facilities. Much more information is 
becoming available about exposure levels for single-walled (SW) CNT and MWCNT, with a 
conclusion being reached that exposures are generally low outside of powder-handling tasks 
(Dahm et al., 2015).
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The sum total of the exposure assessment findings combined with preliminary toxicology 
results allows for exposure-informed toxicological study design and the findings can then be 
integrated, together with available epidemiologic data, to provide health effect relevance. 
While the reality of toxicological science for engineered nanomaterials may have in vivo and 
in vitro studies proceeding without any exposure assessment guidance, every effort should 
be made to push for detailed exposure assessment to provide timely context to the 
toxicology studies.
3. Insights from the carbon nanotube experience
3.1. Initial market projections and toxicity studies
Unprecedented global investment in innovative nanoscale science and engineering has led to 
the production and utilization of novel materials in expanding fields of electronics, 
medicine, and composites. However, health and environmental implications of these new 
critical nanomaterials have raised serious issues. Engineered nanomaterials, such as carbon 
nanotubes (CNT), have caused toxicity in experimental models. Generally, limited data 
exists for human exposures (Liou, Tsai, Pelclova, Schubauer-Berigan, & Schulte, 2015), the 
physicochemical properties most prevalent in exposure scenarios, and health outcomes. 
These deficiencies make interpretation of experimental findings to human relevance difficult.
Early projections had CNT production becoming a multi-billion dollar industry suggesting 
the potential for exposure risk. The projections implied the workforce handling CNT would 
rapidly expand and the CNT market would reach the everyday consumer in the very near 
future. This expected growth led increased in vivo and in vitro toxicology assessment of 
CNT world-wide. The initial in vivo studies evaluating the toxicity of SWCNT clearly 
showed pulmonary toxicity that included inflammation and rapid onset fibrosis following 
exposure (Lam, James, McCluskey, & Hunter, 2004; Mangum et al., 2006; Shvedova et al., 
2005; Warheit et al., 2004). Additional studies on the more market prevalent MWCNT found 
similar results (Ma-Hock et al., 2009; Pauluhn, 2010). These findings were consistent with 
the mode of action for biopersistent fibrous shaped particles. Additional studies provide 
evidence of adverse extrathoracic effects following pulmonary exposure, including 
cardiovascular and immunological responses as well as translocation (Erdely et al., 2009; Li 
et al., 2007; Mercer, Scabilloni, Hubbs, Wang, et al., 2013; Mitchell, Lauer, Burchiel, & 
McDonald, 2009). While early CNT studies clearly illustrated a hazard, there was 
incomplete extrapolation to relevant human health effects. Furthermore, materials 
prominently tested in early studies (e.g., MWCNT-7) were of unknown relevance to actual 
market use. This was not a fault of these studies but an illustration of the lack of data from 
detailed workplace exposure assessments. To date, thousands of articles have been published 
concerning CNT (includes toxicology and application), but very few examine human 
exposure scenarios and health effects.
3.2. Field assessments
The adverse outcomes of the initial toxicology studies combined with market projections 
created the need to assess exposures and the feasibility of human health effect studies 
(Schubauer-Berigan et al., 2011). Initial exposure assessment studies relied on gravimetric 
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area measurements, extrapolations from catalyst, and short duration worst case scenario 
measurements (Erdely et al., 2013). These early exposure assessment studies on CNT 
provided some useful insight while also highlighting needs for future more detailed studies. 
More recent workplace exposure assessments, such as the work by Dahm et al. (2012, 2015), 
provided significant impact for toxicological assessments. Five critical areas of exposure 
assessment became apparent when extrapolating relevance to experimental studies of CNT 
toxicity: 1) What is the level of exposure with health relevant size fractions? 2) What are the 
physicochemical characteristics of the material with the potential for exposure (e.g. CNT are 
mostly agglomerated in human exposure settings)? 3) What are the most common brands 
and types of CNT being utilized in industry, including secondary manipulations of CNT 
such as surface coatings or functionalization? 4) What is the area of future interest with 
potential large scale applications and other downstream uses? and 5) How long is the 
average cumulative exposure of the workforce handling CNT? Recent elucidation of these 
critical areas greatly contributes to the overall interpretation of already published toxicology 
studies, while contributing to future toxicological and epidemiological study design and 
predictions of human health risks.
3.3. Bridging the gap between exposure assessment and inhalation toxicology
Evaluation of background-corrected elemental carbon from all personal breathing zone 
(PBZ) collections from 8 MWCNT facilities found an average inhalable concentration of 
10.6 μg/m3 (arithmetic mean). The field measurements also contributed to an estimated mass 
median aerodynamic diameter derived from the respirable to inhalable ratio that was used to 
predict an alveolar deposition fraction. These measures allowed for a prediction of 
toxicological effects with regard to average exposures seen in the workplace. Following 
MWCNT inhalation, general effects were evident up to 28 days post-exposure at a 
deposition with estimated human equivalence of 7.6 years at 10.6 μg/m3 (Erdely et al., 
2013). The utility of our extrapolations were supported by a recent study exploring human 
health effects from a single facility in Korea (Lee et al., 2015). Lee et al. (2015) indicated 
increased markers of oxidative stress from exhaled breath condensate from workers with an 
average personal sampling of elemental carbon at 8.34 μg/m3 and an average of 4 years of 
exposure. These results were in very close agreement with our extrapolations (Erdely et al., 
2013) and showed the immense utility of combining detailed exposure assessment with 
ongoing in vivo toxicology studies, together with available epidemiologic data, to make a 
reasonable conclusion concerning human relevance.
Our extrapolations (Erdely et al., 2013) and supporting confirmation in a single facility 
human study (Lee et al., 2015) provided a dosing regimen for screening similar 
manufacturing-relevant carbon-based nanomaterials. A screening process representing 
facility-relevant exposures (4 μg deposition) and a high dose which confers pathology (40 μg 
deposition), have been utilized by ongoing nanomaterial studies (e.g. CNT, CNF, graphite 
nanoplates) to evaluate relative potency between and within classes. The premise is very 
similar to that proposed by Landsiedel et al. for using short term inhalation studies (5 day) as 
an early tier screen for nanomaterial potency (Landsiedel et al., 2014). In many cases 
inhalation is simply not feasible and instillation studies may be necessary, but the overall 
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premise of screening materials with standardized outcomes is an extremely valuable first 
step.
Exposure assessment studies (Dahm et al., 2012, 2015) and accompanying human health 
effects studies (Lee et al., 2015; Schubauer-Berigan et al., 2011) provided insight into types 
of CNT utilized by industry as well as the downstream applications and products containing 
these materials. These studies provided data on specific preference of materials, level of 
exposure, years handling a given material, and future direction of the market. Material 
selection for new toxicity testing is facilitated by this life cycle knowledge of particles with 
regard to surface coating or functionalization followed by product incorporation.
Exposure assessments with personal breathing zone measures also provided representation 
of the morphology of the CNT exposure. Recent studies show the majority of the CNT 
exposure is in the inhalable or thoracic size range (i.e., aerodynamic diameter less than about 
100 μm) rather than the respirable size range (i.e., aerodynamic diameter less than about 10 
μm). This was shown for both elemental carbon mass and by TEM (Dahm et al., 2012, 2015; 
Erdely et al., 2013). These field findings can guide in vivo exposures so that a generated 
aerosol or instillate reflects workforce or consumer exposures. This is crucial for 
intratracheal instillation or oropharyngeal aspiration studies. Altering the physicochemical 
characteristics of nanomaterials often influences toxicity, complicating data interpretation. 
This may be further confounded when determining potency for similar classes of materials 
that respond differently to the same dispersion method or a single material with varying 
toxicity depending on the dispersion method (Baisch et al., 2014; Sager et al., 2015). In 
ongoing studies, TEM images from personal breathing zone collections of CNT or CNF 
exposed workers (Dahm et al., 2012, 2015) were compared to TEM images of the same 
material dispersed for ongoing in vivo studies to ensure relevance of the in vivo exposures. 
While the differences in size of the rodent and human respiratory tract must be considered, 
the goal should be to expose rodents to particles with characteristics relevant to human 
exposures. Therefore, extraordinary measures to disperse particles may not produce 
toxicological findings relevant to humans. Establishing similarities between laboratory and 
field exposures provides some evidence that the in vivo studies are representative of human 
health outcomes.
4. Conclusion
Toxicity assessments and estimates of risk to develop exposure limits can generally proceed 
without exposure assessment. However risk characterization is more informed when 
exposure assessment is available. For engineered nanomaterials specifically, detailed 
exposure assessment fills a large void in relating toxicity findings to human health relevance 
from a dosimetry perspective. In conclusion, we recommend the following integrated 
approach between exposure assessment and toxicity testing especially for materials as 
diverse as engineered nanomaterials:
• Market-informed identification of potential hazards and potentially 
exposed populations.
• Initial toxicity screening to drive prioritized assessments of exposure.
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• Development of exposure assessment-informed chronic and sub-chronic in 
vivo studies.
• Conduct of exposure- and hazard-informed epidemiological studies.
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Fig. 1. 
View of the influence of knowledge-of-exposure and knowledge-of-hazard on the relevance 
and reliability of risk assessments. Adapted from the approach previously described (Hoover 
et al., 2014, 2015).
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Fig. 2. 
A framework for integrating exposure assessment and toxicity testing to design, prioritize, 
and interpret exposure- and hazard-informed epidemiological studies. PBZ=personal 
breathing zone.
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